Intellectual Property

Glint Technology is Well Protected by Patents and Licenses

Exclusive worldwide license to drug delivery contact lens technology from the University of Florida through 2029

Cystalens^TM,
Cystaclear^TM,
MoxiLens^TM

5 issued patents and 4 PCT patent applications covering drug delivery contact lens through 2034. Provisionals submitted July 6, 2023.

Letter of intent for rights to a patented cornea crosslinking formulation

Innovative Drug Eluting Contact Lens Platform to Treat Eye Diseases.